Rockefeller Capital Management
YARW

Rockefeller Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Rockefeller Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– – – 3856
2022
Q4 		– Sell
-2
Closed -$400 – 4242
2022
Q3 		$0 Hold
2
– – ﹤0.01% 4418
2022
Q2 		$0 Buy
2
+1
+100% +$419 ﹤0.01% 4417
2022
Q1 		$0 Hold
1
– – ﹤0.01% 4081
2021
Q4 		$1K Hold
1
– – ﹤0.01% 3703
2021
Q3 		$1K Hold
1
– – ﹤0.01% 3628
2021
Q2 		$4K Buy
+1
New +$3.96K ﹤0.01% 3116
2020
Q2 		– Sell
-2
Closed -$21K – 2700
2020
Q1 		$21K Hold
2
– – ﹤0.01% 1507
2019
Q4 		$37K Hold
2
– – ﹤0.01% 1229
2019
Q3 		$36K Buy
+2
New +$32.3K ﹤0.01% 1072

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Rockefeller Capital Management's YARW Position: Q1 2023 in Review

Rockefeller Capital Management held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

Rockefeller Capital Management first reported a position in YARW in Q3 2019 and has held it in 9 quarters since. The position peaked at $37K in Q4 2019. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Rockefeller Capital Management held 0 shares of Yarrow Bioscience, Inc. Common Stock worth $0 as of Q1 2023.
  • Rockefeller Capital Management left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2023.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2023, its #3856 holding.
  • Rockefeller Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2019 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Yarrow Bioscience, Inc. Common Stock position peaked at $37K in Q4 2019.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.